Dizygotic monochorionic twin pregnancies can result in blood chimerism due to in utero twin-to-twin exchange of stem cells. In this case, we examined the proportion of allogeneic red blood cells by flow cytometry and the proportion of allogeneic nucleated cells by digital polymerase chain reaction at 7 months and again at 5 years. We found an increase in the proportion of allogeneic cells from 63% to 89% in one twin, and a similar increase in autologous cells in the other twin from 57% to 84%. A paradigm for stem cell therapy could be modeled on this case: induction of tolerance and chimerism by antenatal transfusion of donor stem cells. The procedure would hold the promise of transplantation and tolerance induction without myeloablative conditioning for inheritable benign hematological diseases such as sickle cell disease and thalassemia.
Introduction
Chimerism of cells of the blood in dizygotic twins has been described in dizygotic monochorionic placentas in association with in vitro fertilization (1) (2) (3) (4) (5) (6) (7) . Blood chimerism has also been reported in dizygotic dichorionic twins (8) . The spontaneous chimerism established in these multiple pregnancies has, in several cases, been confirmed to be maintained over a long period of time, suggesting long-lasting postnatal tolerance. Hemoglobinopathies such as sickle cell disease and thalassemia can be significantly ameliorated by donor blood transfusions, reducing the proportion of cells with disease-associated phenotype (9) . The naturally occurring chimerism of multiple pregnancies could be a paradigm for cellular therapy and the unique feto-uterine immunological environment intentionally used for induction of donor-specific tolerance.
We present additional new data from an investigation into a case of blood chimerism in twins at 5 years of age initially reported by Ekelund et al (10) . Briefly, three pre-embryos were transferred to the uterus of a 38-year old woman following assisted reproductive treatment with intracytoplasmic sperm injection. The three fetuses were seen by scanning at weeks 6, 7, and 8, one fetus in a separate gestational sac, and two fetuses in a common gestational sac with two amniotic cavities. At week 9, spontaneous reduction of the single triplet was observed. The monochorionic diamniotic twin pregnancy continued. Amniocentesis in both amniotic cavities at week 25 revealed distinct fetal karyotypes 46,XX and 46, XY. At week 33 + 3, a cesarean section was done due to twin-to-twin transfusion syndrome. Twin 1 was a slightly hydropic 2265-g boy with hemoglobin 23.6 g/dL (14.6 mmol/L). Twin 2 was a normal 1550-g girl with hemoglobin 12.0 g/dL (7.4 mmol/L). Karyotyping was performed on blood samples at 1 week, and again at 3 months. The first karyotyping revealed that the infants had an identical mix of nucleated cells in their blood: 46, XX [13] /46,XY [17] . At 3 months, karyotyping showed 46, XX [5] /46,XY [6] in the boy and 46,XX [6] /46,XY [6] in the girl. At 3 months, the twins had external and internal genitalia, and reproductive hormone levels, consistent with phenotypic sex. Growth pattern until 5 years of age was within family target height for sex, and psychomotor development was normal.
We here report the quantification at the age of 7 months, and again at the age of 5 years, of the proportion of circulating red blood cells (RBCs) by flow cytometry and of circulating nucleated cells by digital polymerase chain reaction (PCR) in both twins.
Materials and Methods
The study followed the guidelines of the institutional review board of Copenhagen University Hospital and was conducted in accordance with the Helsinki Declaration.
Digital PCR analysis
Genomic DNA was isolated from peripheral whole blood from each twin using the Qiagen DNA Blood Mini kit (Catalogue #51104; Qiagen Inc., Basel, Switzerland) following the blood and body fluid spin protocol. This procedure purified genomic DNA from the nucleated cells in peripheral blood.
Digital PCR was used to determine the percentage of male diploid genomes in each sample. Templates from the ZFX-(encoding zinc finger protein, X-linked) and ZFY-(encoding zinc finger protein, Y-linked) loci were co-amplified in a duplex assay using a common set of primers with chromosome-specific minor groove binder hydrolysis probes (Table 1 ) (11). The reaction was carried out using the 12.765 Digital Array TM chip on the BioMark TM System (Fluidigm, San Francisco, CA). Each chip contains 12 panels that are each subdivided into 765 chambers of 6-nL volume; 6 panels were used per DNA sample, giving a total of 4590 individual reactions for each DNA sample. DNA was diluted to 5 ng/lL, and 10-lL PCR reactions for each panel were set up, containing 29 TaqMan Gene Expression Master Mix (Applied Biosystems, Foster City, CA), 900 nM of each primer, 200 nM of each probe, and 4 lL DNA (20 ng) per panel. The following PCR conditions were used: 50°C for 2 min, 95°C for 10 min, followed by 50 cycles of 15 s for 95°C and 1 min annealing/extension at 60°C.
The actual number of target molecules for each allele was obtained by Poisson-correcting the number of counts obtained using the following equation:
Target molecules ¼ ½À lnððN-PÞ=NÞ Â N N is the total number of wells analyzed, and P is the number of positive wells for the allele being examined.
A diploid male genome contains one copy of the X chromosome and one copy of the Y chromosome, and the percentage of total diploid genome equivalents of male DNA was calculated using the following equation, where ZFY and ZFX are the "target molecules" calculated above:
This percentage is directly comparable to the percentage of male nucleated cells present.
Flow cytometry
Phenotyping was performed with human anti-Rhc (IgM, Institut de Biotechnologies Jacques Boy, Reims, France) for the 7-month samples, another anti-Rhc (IgM, Bio-Rad, Hercules, CA) for the 5-year samples, and a human monoclonal anti-Jka (IgG, MS15, Bio-Rad), followed by secondary antibody labeled with fluorescein isothiocyanate for IgG and with phycoerythrin for IgM Fc (Jackson ImmunoResearch, West Grove, PA).
A gate was positioned around the cluster of RBCs on logarithmic scales of dot plots of forward scatter versus side scatter, and gated events were analyzed on dual-color dot plots.
HLA typing
DNA purified from buccal swabs from each child at age 7 months was used for typing HLA-A, -B, -C and -DRB1 encoding genes and deducing HLA types (Histogenetics, Ossining, NY) (12).
Results
Flow cytometry at 7 months demonstrated two distinct populations of RBCs, one being RhCC i.e. Rhc negative, Jka positive, and the other Rhc positive, Jka negative ( Figure 1 ). Analysis of DNA purified from a buccal swab at 6 months showed that the girl had the genotype RHCC and Y-chromosome negative, and the boy had the genotype RHCc and Y-chromosome positive, thus linking the girl to the RhCC, Jka-positive RBC population and the boy to the Rhc-positive, Jka-negative RBC population. Both twins had exclusively blood group A RhD-positive RBCs.
We assume that early fusion of two individual embryos with different sex preceded the formation of the monochorionic pregnancy, and the unusual karyotype detected in blood was attributable to reciprocal exchange of hematopoietic tissue through the shared placenta.
Digital PCR on genomic DNA purified from peripheral blood nucleated cells at 7 months showed that the male twin had 69.5% (AE standard deviation [SD] 2.5%) nucleated blood cells of the male genotype and that the female twin had 68% (AE SD 2.3%) nucleated blood cells of the male genotype. At the same age, flow cytometry demonstrated 57% RBCs of the phenotype linked to the male twin in the male twin, and 63% RBCs of the male phenotype in the female twin ( Figure 1A and C, and Table 2 ). PCR, polymerase chain reaction. The primers were identical for the ZFX and ZFY amplicons, the probes detected the difference between ZFY and ZFX.
Five years after birth, we repeated the examination. This again demonstrated a remarkably similar composition of the children's blood: the male twin's blood now contained 88.2% (AE SD 3.7%) nucleated cells of the male genotype, and the female twin's blood contained 88.5% (AE SD 2.8%) nucleated cells of the male genotype. Correspondingly, flow cytometry demonstrated 84% RBCs of the phenotype linked to the male twin in the male, and 89% RBCs of the male phenotype in the female twin ( Figure 1B and D) .
Discussion
In our case the initial male predominance was to be expected based on the body weights of the two infants; the male contributed 59% (100 9 2265/(2265 + 1550)) of the total and we assume that the number of stem cells contributed to the common circulation is proportional to body weight. However, over 5 years, the nucleated male cells have increased their proportion to 88.2% and 88.5% in both children, closely reflected in the RBCs. A similar case of chimerism with an equal leukocyte distribution of %90% XY and 10% XX was reported 6 years after birth in dizygotic monochorionic triplets (one female and two monozygotic males) (13) . A slightly shorter replication time of the male stem cells could contribute to the observed male predominance. However, the similarity of proportions in the twins observed here, as well as in the previous report, is remarkable.
Identity between twins for HLA could potentially contribute to immune tolerance. We therefore determined each child's HLA type based on DNA from buccal swabs. One haplotype was presumably shared whereas the other two haplotypes were different. Several mismatches were present that would enable mutual rejection, (Table 3) . Therefore, HLA identity is not the explanation for the long-term chimerism. Clinically relevant reflections can be made from this case. A substantial 89% chimerism of male cells in the girl was attainable without myeloablative conditioning. The degree of chimerism obtained for the girl would be adequate for treatment of, for example, sickle cell anemia. However, for the boy, the observed 16% allogeneic RBCs would not always be sufficient for avoiding donor RBC transfusion in sickle cell anemia. An expansion of the proportion by, for example, a supplementary postnatal administration of donor stem cells from the same donor would be needed.
Maintenance of chimerism could be based on the ability of the fetal peripheral adaptive immune system to generate suppressive regulatory T-cells, thus establishing tolerance to the alloantigens from the other twin (14, 15 ). An alternative explanation could be reciprocal clonal exhaustion-deletion and immune ignorance (16) . This would indeed be possible due to the observed mutual HLA mismatches.
A potential therapeutic exploitation of our observation would be antenatal transplantation of healthy donor hematopoietic stem cells into a fetal recipient with genetic predisposition for severe hematopoietic morbidity, and in some cases also an additional postnatal transplantation of stem cells from the same donor would be needed. Antenatal fetal diagnostics based on cell-free fetal DNA enable detection of fetal genotype already in the first trimester, thus facilitating timely action (17) . Intrauterine hematopoietic stem cell transplantation is being investigated experimentally because of its great promise, to avoid mortality and morbidity related to cytotoxic agents of myeloablative conditioning (18) . The most obvious current clinical application would be treatment of hemoglobinopathies because of the availability of antenatal screening of cell-free fetal DNA early in pregnancy, and the lack of satisfactory alternative postnatal treatment options. However, intrauterine treatment of osteogenesis imperfecta by transplantation with mesenchymal stem cells also is currently being investigated (19). Genomic DNA was isolated from buccal swabs at 6 months after birth. Multiple differences were noted between the twins that would potentially enable mutual rejection.
